UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000037372
Receipt No. R000042549
Scientific Title Development and evaluation of nursing proguram that supports self-management in order for patients who developed Chronic graft-versus-host disease to fullfill paychosocial supports needs
Date of disclosure of the study information 2019/07/14
Last modified on 2022/07/18 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Development and evaluation of nursing proguram that supports self-management in order for patients who developed Chronic graft-versus-host disease to fullfill paychosocial supports needs
Acronym Development and evaluation of nursing proguram that supports self-management in order for patients who developed Chronic graft-versus-host disease to fullfill paychosocial supports needs
Scientific Title Development and evaluation of nursing proguram that supports self-management in order for patients who developed Chronic graft-versus-host disease to fullfill paychosocial supports needs
Scientific Title:Acronym Development and evaluation of nursing proguram that supports self-management in order for patients who developed Chronic graft-versus-host disease to fullfill paychosocial supports needs
Region
Japan

Condition
Condition after hematopoietic cell transplantation
chronic graft-versus-host disease
Classification by specialty
Nursing
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 evaluate the effectiveness and the usefulness of the self-management support program for the patient whom chronic GVHD developed in to fuifill psychosocial support needs.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes self management for managing Chornic Diseaase 6item scale and fulfill psychosocial support needs scale
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 A period of the intervention: I evaluate it just after the third intervention before the offer intervention of three times of nursing programs in total once a month three months after intervention
Interventions/Control_2 The group which usually receives care
Just after the agreement acquisition, it is evaluated six months after the agreement acquisition two months later by the agreement acquisition
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Male and Female
Key inclusion criteria When it is GVHD chronic than the chief physician receive explanation
continue foreign going to hospital
There is not the sign of the recurrence
of blood forming organ tumor
It is less than three years after hematopoietic cell transplant
Chronic GVHD diagnostic criteria disease severity judgment score 1 3
There is a living together family
The chief physician and a charge nurse judge study entry to be possible
Communication in Japanese is possible
understand the purpose of the study, and an agreement is provided for participation
Key exclusion criteria need hospital care in chronic GVHD diagnostic criteria disease severity judgment score 3 or more
The thing which is hospitalized by the recurrence of the underlying disease
Dejection and depression targeted for medical treatment and the specialized cognitive-behavioral therapy are diagnosed
Mental and physical pain is remarkable, and the participation in nursing program burdens you
The thing that communication in Japanese is impossible
For study entry of the agreement is not provided
Target sample size 60

Research contact person
Name of lead principal investigator
1st name Yukie
Middle name
Last name Hosoda
Organization St Luke's International Hospital
Division name Nursing department
Zip code 104-8560
Address 9-1,Akashicho,Chuo-ku,Tokyo
TEL 03-3541-2511
Email y-hosoda@slcn.ac.jp

Public contact
Name of contact person
1st name Yukie
Middle name
Last name Hosoda
Organization osaka metropolitan University
Division name The Graduate School of Nursing
Zip code 583-8555
Address 3-7-30 habikino,habikinocity,osaka
TEL 072-950-2111
Homepage URL
Email db601007@st.osakafu-u.ac.jp

Sponsor
Institute osaka prefecture University
Institute
Department

Funding Source
Organization Incorporated administrative agency Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka metropolitan Univetsity
Address 3-7-30 habikino,habikinocity,osaka
Tel 072-951-2111
Email db601007@st.osakafu-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2019 Year 05 Month 20 Day
Date of IRB
2019 Year 02 Month 20 Day
Anticipated trial start date
2019 Year 05 Month 20 Day
Last follow-up date
2022 Year 08 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 07 Month 14 Day
Last modified on
2022 Year 07 Month 18 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000042549